目的:制备GPR48的单克隆抗体,并且初步评估其在体外对子宫颈癌细胞侵袭转移的抑制作用。方法:纯化的GPR48特异性片段作为抗原,细胞融合法制备GPR48单克隆抗体,蛋白免疫印迹法检测单克隆抗体的特异性,用体外侵袭性实验检测该单抗抑制子宫颈癌细胞Hela侵袭转移的作用。结果:制备了效价高、特异性好的GPR48单克隆抗体。当加入10nmol/L浓度的单克隆抗体时,对照组和实验组的穿膜细胞数分别为280±18、73±11;而当加入单抗浓度为50nmol/L时,对照组和实验组的穿膜细胞数分别为267±30、14±3。结论:G PR48单克隆抗体在体外能够显著抑制子宫颈癌细胞的侵袭转移。
Objective :To obtain mouse anti -human GPR48 monoclonal antibodies and to estimate the inhibition effect on invasion and metastasis of cervical neoplasm cells in vitro. Methods :The monoclonal antibody of GPR48 was produced by cell fusion and identified by Western blotting. Then the inhibition effect on cancer cells invasion and me- tastasis was measured by Matrigel invasion assay in vitro. Results :The monoclonal antibody of GPR48 was prepared. When we added 10 nmol/L IgG or GPR48 antibody into the migration assay, the number of migrated ceils was (280 + 18) vs (73 ± 11). When we added 50 nmol/L antibody,the number of migrated cells was (267 ±30) vs (14 ± 3). Condusion:GPR48 mAb showed the high specificity to GPR48 with strong affnity and efficient suppression on invasion and metastasis of Hela cells in vitro.